North American Prostate Cancer Diagnostics and Therapeutics Market Will Generate Record Revenue by 2025
North American prostate cancer diagnostics and therapeutics market is expected to grow at a CAGR of 10.4% during the forecast period. The major factors for the growth of the market include the high prevalence of prostate cancer in the region which raises the demand for efficient diagnostics and therapies for the treatment of cancer. As per World Health Organization, in the North America, prostate cancer is the most prevalent cancer among men. Around 234,000 new cases of prostate cancer has been registered in 2018 in the region. Additionally, in 2018, around 18.5% of the total cases of cancer are related to prostate cancer in the US. Moreover, the adoption of innovative technologies for the diagnosis of prostate cancer such as biomarkers and the adoption of personalized medicine for treatment is expected to fuel the market.
(Get 25% Discount on Buying this Report)
To Request a Sample of our Report on Peptide
and Anticoagulant Drug Market: https://www.omrglobal.com/request-sample/north-american-prostate-cancer-diagnostic-therapeutic-market
North American prostate cancer
diagnostic market is divided on the basis of diagnostic technique and
therapeutics. By diagnostic technique, the market is segmented into
prostate-specific antigen test, digital rectal examination, prostate biopsy,
imaging techniques. Prostate biopsy is expected to hold a major market share
during the forecast period. By therapeutics, the market is segmented into
hormonal therapy, chemotherapy, immunotherapy, radiation therapy, targeted
therapy, surgery. During the forecast period, chemotherapy is expected to have
a major market share in the region. Geographically, the market is divided into
the US and Canada. The US is expected to hold the major major market share
during the forecast period.
A
full Report of North American Prostate Cancer Diagnostics and Therapeutics
Market is Available @
https://www.omrglobal.com/industry-reports/north-american-prostate-cancer-diagnostic-therapeutic-market
North American Prostate
Cancer Market Segmentation
By Diagnostic Techniques
·
Prostate-Specific Antigen Test (PSA)
·
Digital Rectal Examination
·
Prostate Biopsy
·
Imaging Techniques
By Therapeutics
·
Hormonal Therapy
·
Chemotherapy
·
Immunotherapy
·
Radiation Therapy
·
Targeted Therapy
·
Surgery
Regional Analysis
·
United States
·
Canada
Company Profiles
·
Abbott Laboratories
·
AbbVie Products, LLC
·
Amgen Inc.
·
AstraZeneca PLC
·
Bavarian Nordic A/S
·
Bayer AG
·
Bristol-Myers Squibb Co.
·
Endo Pharmaceuticals Inc.
·
Ferring Pharmaceuticals Inc.
·
GlaxoSmithKline PLC
·
Johnson & Johnson
·
Pfizer Inc.
·
Siemens Healthcare AG
·
Decipher Biosciences, Inc.
·
Nanostics Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment